Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083521 · ClinicalTrials.gov registry record · NA
Effect of Bacillus Subtilis DE111® on Daily Bowel Movements
A NA study, sponsored by Deerland Enzymes.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04083521: Completed NA study, sponsored by Deerland Enzymes.
NCT04083521 is a NA study that has completed, run by Deerland Enzymes. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04083521, a NA study, has completed, sponsored by Deerland Enzymes.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.
Primary Outcome
Increasing regularity of bowel movements in subjects with occasional diarrhea or constipation
Interventions
- DIETARY_SUPPLEMENT Bacillus subtilis DE111®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
What the finished NCT04083521 record still lists
NCT04083521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Bacillus subtilis DE111® is the first listed.
NCT04083521 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04083521 about?
NCT04083521 is a clinical study titled "Effect of Bacillus Subtilis DE111® on Daily Bowel Movements". The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.
What is the current status of trial NCT04083521?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-09-01. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT04083521?
The interventions under investigation include: Bacillus subtilis DE111® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04083521?
This trial is sponsored by Deerland Enzymes, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04083521's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI